Inactive Instrument

Transcripts Olainfarm AS Nasdaq Riga

Stocks

OLF1R

LV0000100501

Pharmaceuticals

End-of-day quote Nasdaq Riga
- ^LVL	-

07/21/07	AS "AB CITY" completed the acquisition of an additional 49.19% stake in AS Olainfarm from a group of shareholders for €64.2 million.	CI
12/21/12	Olainfarm Board OKs AB City's Mandatory Share Buyback Offer	MT

Transcripts

31/21/31	AS Olainfarm, Q2 2021 Earnings Call, Aug 31, 2021
02/21/02	AS Olainfarm, Q1 2021 Earnings Call, Jun 02, 2021
02/21/02	AS Olainfarm, Q4 2020 Earnings Call, Mar 02, 2021
26/21/26	AS Olainfarm Provides Consolidated and Standalone Earnings Guidance for the Year 2021	CI
02/20/02	AS Olainfarm, Q3 2020 Earnings Call, Dec 02, 2020
30/20/30	Olainfarm Group Provides Group and Parent Company Earnings Guidance for the Year 2020	CI
02/20/02	AS Olainfarm, Q2 2020 Earnings Call, Sep 02, 2020
02/20/02	Olainfarm Group Provides Earnings Guidance for the Year 2020	CI
03/20/03	AS Olainfarm, Q1 2020 Earnings Call, Jun 03, 2020
29/20/29	AS Olainfarm Provides Earnings Guidance for the Year 2020	CI
30/20/30	JSC Olainfarm Provides Earnings Guidance for the Year 2020	CI
13/20/13	AS Olainfarm Provides Earnings Guidance for Group and Company for the Year 2020	CI
11/20/11	AS Olainfarm, Q4 2019 Earnings Call, Mar 11, 2020
23/20/23	AS Olainfarm Announces Consolidated and Unconsolidated Sales Results for the Month and Year to Date Ended December 2019; Provides Earnings Guidance for the Year 2020	CI
22/19/22	JSC Olainfarm Provides Unconsolidated and Consolidated Sales Guidance for the Full Year 2019	CI
12/19/12	AS Olainfarm Announces Consolidated and Unconsolidated Sales Results for the Month of June and Six Months Ended June 2019; Provides Consolidated and Unconsolidated Sales Guidance for the Year 2019	CI
14/19/14	As Olainfarm Announces Consolidated and Unconsolidated Sales Results for the Month of May and Five Months Ended May 2019; Provides Consolidated and Unconsolidated Sales Guidance	CI
15/19/15	AS Olainfarm Announces Preliminary Consolidated and Unconsolidated Sales Results for the Month and Four Months Ended of April 2019; Provides Consolidated and Unconsolidated Sales Guidance for the Year 2019	CI
16/19/16	AS Olainfarm Provides Unconsolidated and Consolidated Sales Guidance for the Year 2019	CI
15/19/15	JSC Olainfarm Reports Preliminary Consolidated and Unconsolidated Sales Results for the Month and Two Months Ended February 2019; Provides Consolidated and Unconsolidated Sales Guidance for the Year 2019	CI
17/18/17	JSC Olainfarm Reports Preliminary Consolidated and Unconsolidated Sales Results for the Month and Eleven Months Ended November 2018; Provides Consolidated and Unconsolidated Sales Outlook for the Year 2018	CI
18/18/18	AS Olainfarm Reports Consolidated and Non-Consolidated Sales Results for the Month and Nine Months Ended September 2018; Provides Consolidated and Non-Consolidated Turnover Guidance for the Year 2018	CI
21/18/21	JSC Olainfarm Reports Preliminary Consolidated and Non-Consolidated Sales Results for the Month and Year to Date Ended August 2018; Provides Sales Guidance for the Year 2018	CI
17/18/17	AS Olainfarm Announces Preliminary Consolidated and Unconsolidated Sales Results for the Month and Four Months Ended of April 2018; Provides Sales Guidance for the Year 2018	CI
17/16/17	Olainfarm Pharmaceutical Announces Preliminary Consolidated and Unconsolidated Sales Results for the Month and Year-To-Date Ended April 2016; Provides Consolidated and Unconsolidated Sales Guidance for 2016	CI